☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Insights+: The US FDA New Drug Approvals in March 2022
April 21, 2022
Servier Publishes Results of Tibsovo (ivosidenib) in P-III (AGILE) Trial for IDH1-Mutated Acute Myeloid Leukemia in NEJM
April 21, 2022
Otonomy Reports Results of OTO-413 in P-IIa Clinical Trial for the Treatment of Hearing Loss
April 21, 2022
Ultragenyx Reports the First Patient Dosing of Setrusumab (UX143) in P-II/III (Orbit) Study for the Treatment of Osteogenesis Impe...
April 21, 2022
AstraZeneca Reports Results of Evusheld in P-III (PROVENT) Trial for the Treatment of Symptomatic COVID-19
April 21, 2022
Boehringer Ingelheim Entered into a Research Agreement with VantAI to Identify Novel Protein Degraders
April 21, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions